GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for the continued development and ...

Tuberculosis is the world's leading infectious cause of death, killing more than one million people each year. When the ...

LONDON, UK I June 12, 2025 I GSK plc (LSE/NYSE: GSK) announced today that it has licensed its Shigella vaccine candidate, altSonflex1-2-3, to Bharat Biotech ...

Under terms of the deal, Bharat Biotech will lead late-stage development and scale-up of the altSonflex1-2-3 Shigella vaccine ...

Scientists developed nanoparticles that respond to warmth inside tumors to boost ultrasound clarity, offering a safer and ...

New research reveals TB bacteria ramp up production of tiny protein packets during iron shortages. These packets help them ...

Therefore, biological therapy has become the focus of researches on degenerative orthopedic diseases. Extracellular vesicles (EVs), with superior properties of immunoregulatory, growth support, and ...

reported a bioengineered OMV-based platform using bacterial OMVs as nanocarriers to encapsulate ... which was introduced with the OmpA signal peptide SP. Three bioengineered outer membrane vesicles ...

This study was approved by the University of Connecticut Institutional Biosafety Committee. The role of fibronectin in the invasion of INT407 cells by E. sakazakii was analyzed by pretreating the ...

Taiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei 11529, Taiwan Graduate Institute of Nanomedicine and Medical ...

Biological Physics Laboratory, Department of Physics and Astronomy, Faculty of Science and Engineering, The University of Manchester, Oxford Road, Manchester M13 9PL, UK Division of Pharmacy and ...